Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr;30(2):529-555.
doi: 10.1128/CMR.00033-16.

Clinical Manifestations, Treatment, and Diagnosis of Tropheryma whipplei Infections

Affiliations
Review

Clinical Manifestations, Treatment, and Diagnosis of Tropheryma whipplei Infections

Ruben A V Dolmans et al. Clin Microbiol Rev. 2017 Apr.

Abstract

Whipple's disease is a rare infectious disease that can be fatal if left untreated. The disease is caused by infection with Tropheryma whipplei, a bacterium that may be more common than was initially assumed. Most patients present with nonspecific symptoms, and as routine cultivation of the bacterium is not feasible, it is difficult to diagnose this infection. On the other hand, due to the generic symptoms, infection with this bacterium is actually quite often in the differential diagnosis. The gold standard for diagnosis used to be periodic acid-Schiff (PAS) staining of duodenal biopsy specimens, but PAS staining has a poor specificity and sensitivity. The development of molecular techniques has resulted in more convenient methods for detecting T. whipplei infections, and this has greatly improved the diagnosis of this often missed infection. In addition, the molecular detection of T. whipplei has resulted in an increase in knowledge about its pathogenicity, and this review gives an overview of the new insights in epidemiology, pathogenesis, clinical manifestations, diagnosis, and treatment of Tropheryma whipplei infections.

Keywords: PCR; Tropheryma whipplei; Whipple's disease; antibiotics; clinical manifestations; histopathology; therapy.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Schematic representation of the diagnostic algorithm. (A) Diagnostic strategy for classic Whipple's disease (WD). (B) Diagnostic strategy for chronic localized T. whipplei infection.
FIG 2
FIG 2
Microscopic detection of T. whipplei-infected duodenal mucosa. (Top) Hematoxylin-and-eosin-stained duodenal biopsy specimens with foamy macrophages in the lamina propria (arrows). The specimens were photographed with a 20× (left) and 40× (right) lens objective. (Bottom) Periodic acid-Schiff-diastase (PAS-D)-stained duodenal biopsy specimens with PAS-D-positive granules in the foamy macrophages (arrows). The same duodenal biopsy specimens as those used in the top panels were used here. The specimens were photographed with a 20× (left) and 40× (right) lens objective.
FIG 3
FIG 3
Latest proposed therapeutic strategy to treat T. whipplei infections. See the text for explanation.
None
None
None
None

Similar articles

Cited by

References

    1. Whipple GH. 1907. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Bull Johns Hopkins Hosp 18:382–393.
    1. Paulley JW. 1952. A case of Whipple's disease (intestinal lipodystrophy). Gastroenterology 22:128–133. - PubMed
    1. Cohen AS, Schimmel EM, Holt PR, Isselbacher KJ. 1960. Ultrastructural abnormalities in Whipple's disease. Proc Soc Exp Biol Med 105:411–414. doi:10.3181/00379727-105-26126. - DOI - PubMed
    1. Yardley JH, Hendrix TR. 1961. Combined electron and light microscopy in Whipple's disease. Demonstration of “bacillary bodies” in the intestine. Bull Johns Hopkins Hosp 109:80–98. - PubMed
    1. Wilson KH, Blitchington R, Frothingham R, Wilson JA. 1991. Phylogeny of the Whipple's-disease-associated bacterium. Lancet 338:474–475. doi:10.1016/0140-6736(91)90545-Z. - DOI - PubMed

Substances

LinkOut - more resources